What is Multimel N4-550E used for?

This medicinal product is for diagnostic use only. After reconstitution with Sodium Pertechnetate ( 99m Tc) Injection, the product is indicated in adults for: (1) Technetium ( 99m Tc) Exametazime Injection is indicated for brain scintigraphy. The product is to be used for the diagnosis of abnormalities of regional cerebral blood flow, such as those occurring following stroke and other cerebrovascular disease, epilepsy, Alzheimer's disease and other forms of dementia, transient ischaemic attack,

How does Multimel N4-550E work?

Pharmacotherapeutic group: diagnostic radiopharmaceuticals, central nervous system, ATC code: V09AA01 Pharmacotherapeutic group: diagnostic radiopharmaceuticals, inflammation and infection detection, ATC code: V09HA02 At the chemical concentrations and activities used for diagnostic procedures technetium-99m exametazime and technetium-99m-labelled leucocytes do not appear to exert any pharmacodyna

What is the active ingredient in Multimel N4-550E?

Preparat złożony (Alaninum, Arginina, Calcii chloridum dihydricum, Glicyna, Glucosum monohydratum, Histidinum, Kalii chloridum, Leucinum, Lysini hydrochloridum, Magnesii chloridum hexahydricum, Methioninum, Natrii acetas trihydricus, Natrii glycerophosphas pentahydricus, Phenylalaninum, Serinum, Soiae oleum raffinatum, Treoninum, Tryptophanum, Tyrosinum, Valinum, izoleucyna, prolina)

Is Multimel N4-550E OTC or prescription only?

Multimel N4-550E requires a doctor's prescription.

What are the side effects of Multimel N4-550E?

The frequencies of undesirable effects are defined as follows: Very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000) and not known (cannot be estimated from the available data) Immune system disorders Not known: Hypersensitivity including rash, erythema, urticaria, angioedema, pruritus. Re-injected Ceretec labelled leukocytes only: Not known: Hypersensitivity including rash, erythema, urticaria, angioedema, pruritus, ana

Who should NOT take Multimel N4-550E?

Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.

Does Multimel N4-550E interact with other medications?

No interaction studies have been performed.

Can Multimel N4-550E be used during pregnancy?

Women with childbearing potential When an administration of radiopharmaceuticals to a woman of childbearing potential is intended, it is important to determine whether or not she is pregnant. Any woman who has missed a period should be assumed to be pregnant until proven otherwise. If in doubt about her potential pregnancy (if the woman has missed a period, if the period is very irregular, etc.), alternative techniques not using ionising radiation (if there are any) should be offered to the pati

What precautions should be taken with Multimel N4-550E?

General warning Radiopharmaceuticals should be received, used and administered only by authorised persons in designated clinical settings. Its receipt, storage, use, transfer and disposal are subject to the regulations and/or appropriate licences of the competent official organisation. Radiopharmaceuticals should be prepared in a manner which satisfies both radiation safety and pharmaceutical quality requirements. Appropriate aseptic precautions should be taken. Contents of the vial are intended

Who manufactures Multimel N4-550E?

Baxter Polska Sp. z o.o. (Belgia)

What ATC class does Multimel N4-550E belong to?

Multimel N4-550E: ATC B05BA10. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

Multimel N4-550E

komora z 10% emulsją tłuszczową (co odpowiada 10 g/100 ml) (200 ml) - 20,00 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 4,56 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 2,53 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 2,27 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 1,06 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 1,32 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 1,61 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 1,60 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 0,88 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 1,23 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 1,50 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 1,10 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 0,92 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 0,40 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 0,09 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 1,28 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 0,98 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 2,14 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 1,19 g + komora z 5,5% roztworem aminokwasów (co odpowiada 5,5 g/100 ml) (400 ml) - 0,45 g + komora z 20% roztworem glukozy (co odpowiada 20 g/100 ml) (400 ml) - 88,00 g + komora z 20% roztworem glukozy (co odpowiada 20 g/100 ml) (400 ml) - 0,30 g, Emulsja do infuzji

INN: Preparat złożony

Data updated: 2026-04-13

Available in:

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.